Insight Molecular Diagnostics Inc. IMDX
2.39 USD -0.08 (-3.24%)
At closeNov 11, 2026, 4:00 PM EST
2.39 0.00 0.00%
After hours · Nov 11, 4:00 PM ET
2.36 Day range 2.65
2.35 52-week range 8.51
- YTD
- -68.13%
- 1 year
- -68.26%
- Market cap
- 78.21M
- EPS (ttm)
- -1.52
- YTD return
- -68.13%
- 1-year return
- -68.26%
- Volume
- 183.29K
- Avg volume
- 238.75K
- Open
- 2.50
- Previous close
- 2.47
- Day's range
- 2.36 – 2.65
- 52-week range
- 2.35 – 8.51
No chart data for this range yet.
Financials — quick view
IMDX Revenue — quarterly 239.00K
IMDX Net income — quarterly -11.26M
IMDX EPS — quarterly -0.31
News
Aclaris Therapeutics (NASDAQ:ACRS) vs. Oncocyte (NASDAQ:IMDX) Financial Contrast 
iMDx to Release Third Quarter Results on November 16, 2026 
iMDx Amends Chronix Merger Agreement, Replacing Ongoing 10% CNI Monitor Royalty With 10% Sale Payment Upon CNI Monitor Sale 
LUCID CAPITAL MARKETS Initiates Coverage On Insight Molecular with Buy Rating, Announces Price Target of $8 
Transcript: Insight Molecular Q2 2026 Earnings Conference Call - Insight Molecular Diagnostics To Host Virtual KOL Event On August 17 To Discuss GraftAssure Platform Leveraging Digital PCR Technology For Reliable dd-cfDNA Results In Transplanted Organ Health Monitoring
CORRECTION: Insight Molecular Q2 Adj. EPS $(0.23) Beats $(0.24) Estimate, Sales $239.000K Miss $437.500K Estimate - 12 Health Care Stocks Moving In Friday's After-Market Session
Insight Molecular Q1 2026 Earnings Call Transcript - Insight Molecular Q1 Adj. EPS $(0.28) Misses $(0.26) Estimate, Sales $32.000K Miss $300.000K Estimate
Your note
Sign in to keep a note on IMDX — it syncs with the Stock Master app.